IP Library Patent Application 13085355
Patent Application
App. No. 13/085,355

RF Tissue Modulation Devices and Methods of Using the Same

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/085,355
Abstract

Minimally invasive RF tissue modulation devices are provided. In some aspects, the devices include a hand-held control unit and an elongated member. The hand-held control unit includes an electrical energy source and the elongated member has a proximal end operably coupling to the hand-held control unit. The RF tissue modulation device is configured to generate a plasma at a distal end plasma generator for a therapeutic duration. In some aspects, RF tissue modulation devices are provided and include an adapter that operably couples to a hand-held medical device. The adapter generates RF energy for delivery to a plasma generator on an elongated member. Methods of delivering the RF energy to the internal target tissue site are also provided.

Claims (37)

1 . A minimally invasive RF tissue modulation device, the device comprising:

(a) a hand-held control unit comprising an electrical energy source; and

(b) an elongated member having a proximal end operably coupled to the hand-held control unit and a minimally-dimensioned distal end comprising a plasma generator;

wherein the device is configured to generate a plasma at the plasma generator for a therapeutic duration.

2 . The device according to claim 1 , wherein the device comprises a voltage converter, a charge accumulator and an RF signal generator collectively operably coupling the electrical energy source to the plasma generator.

3 . The device according to claim 2 , wherein the RF signal generator comprises a power amplifier and an RF clock source.

4 - 5 . (canceled)

6 . The device according to claim 3 , wherein the voltage converter is configured to receive a first signal from the charge accumulator and to output a second signal to the RF signal generator.

7 . (canceled)

8 . The device according to claim 3 , wherein the charge accumulator is configured to receive a first signal from the voltage converter and to output a second signal to the RF signal generator.

9 . The device according to claim 1 , wherein the electrical energy source comprises one or more batteries.

10 . The device according to claim 2 , wherein the voltage converter is a DC to DC converter.

11 . The device according to claim 2 , wherein the charge accumulator comprises a single capacitor.

12 . The device according to claim 2 , wherein the charge accumulator comprises a set of two or more capacitor pairs.

13 . The device according to claim 12 , wherein the device comprises a demultiplexer configured to produce a modulated signal output from the set.

14 . The device according to claim 13 , wherein each capacitor pair of the set is coupled to the demultiplexer by a transistor.

15 . The device according to claim 14 , wherein the transistor is a bipolar junction transistor.

16 . (canceled)

17 . The device according to claim 1 , further comprising a band pass filter.

18 . The device according to claim 1 , further comprising a tuner.

19 . The device according to claim 1 , wherein the therapeutic duration is 1 second or longer.

20 . (canceled)

21 . The device according to claim 1 , wherein the device is configured to have a minimum recharge period between plasma generation.

22 . (canceled)

23 . The device according to claim 1 , wherein the plasma generator is configured to produce a plasma arc between a first conductive member positioned inside of the distal end of the elongated member and an outer surface of the elongated member.

24 - 31 . (canceled)

32 . The device according to claim 1 , wherein the elongated member is configured to be detachable from the hand-held control unit.

33 . A method of delivering RF energy to an internal target tissue site of a subject, the method comprising:

(a) positioning the distal end of an elongated member of a device according to claim 1 at the internal target tissue site of a subject; and

(b) generating a plasma from the plasma generator to deliver RF energy to the internal target tissue site of the subject.

34 - 37 . (canceled)

38 . An adapter comprising:

an electrical energy source; and

a voltage converter;

a charge accumulator; and

an RF signal generator.

39 - 76 . (canceled)

Assignments (5)
SECURITY AGREEMENT Recorded Aug 26, 2022
From: TRICE MEDICAL, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND, LP
Reel/Frame 061328/0121 →
CHANGE OF NAME Recorded Sep 10, 2014
From: INSYTE MEDICAL TECHNOLOGIES, INC.
To: TRICE MEDICAL, INC.
Reel/Frame 033715/0861 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNMENT DOCUMENT PREVIOUSLY RECORDED ON REEL 029290 FRAME 0252. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNORS INTEREST. Recorded Nov 19, 2012
From: AXIS SURGICAL TECHNOLOGIES, INC.
To: INSYTE MEDICAL TECHNOLOGIES, INC.
Reel/Frame 029339/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2012
From: AXIS SURGICAL TECHNOLOGIES, INC.
To: INSYTE MEDICAL TECHNOLOGIES, INC.
Reel/Frame 029290/0252 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2011
From: CYBULSKI, JAMES S.
To: AXIS SURGICAL TECHNOLOGIES, INC.
Reel/Frame 026831/0450 →